Next Article in Journal
Optimization of Xylanase Production from Penicillium sp.WX-Z1 by a Two-Step Statistical Strategy: Plackett-Burman and Box-Behnken Experimental Design
Next Article in Special Issue
Neuroprotective Effects of Erucin against 6-Hydroxydopamine-Induced Oxidative Damage in a Dopaminergic-like Neuroblastoma Cell Line
Previous Article in Journal
Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin
Previous Article in Special Issue
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke
Review

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease

Department of Biotechnology, Konkuk University, Chungju 380-701, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(8), 10608-10629; https://doi.org/10.3390/ijms130810608
Received: 26 July 2012 / Revised: 13 August 2012 / Accepted: 14 August 2012 / Published: 23 August 2012
(This article belongs to the Special Issue Neuroprotective Strategies 2012)
Parkinson’s disease (PD), a neurodegenerative movement disorder of the central nervous system (CNS) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta region of the midbrain. Although the etiology of PD is not completely understood and is believed to be multifactorial, oxidative stress and mitochondrial dysfunction are widely considered major consequences, which provide important clues to the disease mechanisms. Studies have explored the role of free radicals and oxidative stress that contributes to the cascade of events leading to dopamine cell degeneration in PD. In general, in-built protective mechanisms consisting of enzymatic and non-enzymatic antioxidants in the CNS play decisive roles in preventing neuronal cell loss due to free radicals. But the ability to produce these antioxidants decreases with aging. Therefore, antioxidant therapy alone or in combination with current treatment methods may represent an attractive strategy for treating or preventing the neurodegeneration seen in PD. Here we summarize the recent discoveries of potential antioxidant compounds for modulating free radical mediated oxidative stress leading to neurotoxicity in PD. View Full-Text
Keywords: Parkinson’s disease; oxidative stress; free radicals; antioxidants; neuroprotection Parkinson’s disease; oxidative stress; free radicals; antioxidants; neuroprotection
Show Figures

MDPI and ACS Style

Koppula, S.; Kumar, H.; More, S.V.; Kim, B.W.; Kim, I.S.; Choi, D.-K. Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease. Int. J. Mol. Sci. 2012, 13, 10608-10629. https://doi.org/10.3390/ijms130810608

AMA Style

Koppula S, Kumar H, More SV, Kim BW, Kim IS, Choi D-K. Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease. International Journal of Molecular Sciences. 2012; 13(8):10608-10629. https://doi.org/10.3390/ijms130810608

Chicago/Turabian Style

Koppula, Sushruta, Hemant Kumar, Sandeep Vasant More, Byung Wook Kim, In Su Kim, and Dong-Kug Choi. 2012. "Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease" International Journal of Molecular Sciences 13, no. 8: 10608-10629. https://doi.org/10.3390/ijms130810608

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop